New treatment for children with Acute Respiratory Distress Syndrome

ScienceDaily. Published online: 6 May 2016

Image shows a supine radiograph of patient with plasmodium falciparum: acute respiratory distress syndrome.

Acute Respiratory Distress Syndrome (ARDS) affects hundreds of thousands of people each year, many of them children. Those with this life threatening condition have severely injured and wet lungs, and are treated with mechanical ventilation. Now, a study led by Professor Kanwaljeet Anand published in Frontiers in Pediatrics, investigates the effects of a new steroid treatment on children suffering from ARDS.

“Over the last 20-30 years researchers have come up with novel therapies but have not been able to move the needle substantially in terms of reducing mortality of ARDS patients,” explains Professor Anand of Stanford University, USA. “In this work, we conducted the first-ever randomized control trial and saw clinical differences in children treated with steroids.”

ARDS is a catch-all term associated with the inability of lung tissue to take up oxygen, the lungs become very stiff and are incapable of transferring oxygen into the blood. ARDS can occur following direct injury of the lungs, such as pneumonia, bronchiolitis, following inhalation of toxic gas and near drowning. It can also develop in patients with severe systemic illnesses. Understanding why ARDS occurs and the differences between mechanisms is key to being able to treat ARDS effectively.

Read the full commentary here

Read the full article here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s